https://ift.tt/2IVHF6y

Thus far in the calendar year 2018, Thyrocare had underperformed the market by falling 14% as compared to 8.6% rise in the S&P BSE Sensex till Friday.

from Markets https://ift.tt/2K7wOC8

Comments

Popular posts from this blog

MPL accuses ASCI of 'tampering' with ads